अApnaFunda

AETHER INDUSTRIES LIMITED (AETHER)

Process Industries · Chemicals: Major Diversified · figures to Nov '26

Quality scoreHow the business itself ranks against its sector peers on profitability, 3-year growth and leverage. 50 is the middle of the sector.79 / 100
Profitability 75Growth 83Balance sheet 80
Momentum scoreHow strong the recent trend is: 3-month price change, 12-month improvement in earnings and the rise in FII + DII holding, among companies above ₹500 cr.53 / 100
Price 65Earnings 60FII/DII 34

Passes these screensHigh Momentum

Share price

Closing priceAdjusted for splits and bonus issues.

₹1,590.1 latest close · +17.0% over the last 90 sessions

₹1,400₹1,600₹1,800Jul 3Jul 29Aug 24Sep 17Oct 14Nov 9 ₹1,400₹1,600₹1,800Jul 3Sep 4Nov 9

₹1,590.1 month-end · +81.3% over 12 months

₹1,000₹1,500Nov '25Jan '26Apr '26Jun '26Sep '26Nov '26 ₹1,000₹1,500Nov '25May '26Nov '26

₹1,590.1 month-end · +103.9% over 3 years

₹1,000₹1,500Nov '23Jun '24Jan '25Sep '25Apr '26Nov '26 ₹1,000₹1,500Nov '23May '25Nov '26

₹1,590.1 month-end · +103.7% since Jun '22

₹1,000₹1,500Jun '22May '23Mar '24Feb '25Dec '25Nov '26 ₹1,000₹1,500Jun '22Sep '24Nov '26

52-week range ₹728.00 to ₹1814.10 · 1-year volatility 42.4%

Was the rally earned?

+81%share price, 1 yearEarnings and multiple

Both mattered.

  • Per-share earnings added 40 points and the multiple added 41 points (P/E 66.3x to 89.7x).
  • The share count barely moved.
Net profit growth: +41 pts. Points of the price return explained by net profit growing (or shrinking).+41 ptsNet profit growthP/E change: +41 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+41 ptsP/E changeShare count change: −1 pts. Points of the price return explained by the share count changing. More shares count against the price.−1 ptsShare count changeShare price: +81%+81%Share priceNet profit growth: +41 pts. Points of the price return explained by net profit growing (or shrinking).+41ProfitP/E change: +41 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+41P/EShare count change: −1 pts. Points of the price return explained by the share count changing. More shares count against the price.−1SharesShare price: +81%+81%Share price
Net profit growth+41 ptsNet profit rose about 34%, which lifts the price.
P/E change+41 ptsThe P/E rose from 66.3x to 89.7x, which lifts the price.
Share count change-1 ptsShare count was little changed. More shares would count against the price.
+104%share price, 3 yearsEarnings-driven

Mostly yes.

  • Per-share earnings added 77 points to the rise, while the multiple moved less (P/E 74.5x to 89.7x).
  • The share count rose 7%.
Net profit growth: +87 pts. Points of the price return explained by net profit growing (or shrinking).+87 ptsNet profit growthP/E change: +27 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+27 ptsP/E changeShare count change: −10 pts. Points of the price return explained by the share count changing. More shares count against the price.−10 ptsShare count changeShare price: +104%+104%Share priceNet profit growth: +87 pts. Points of the price return explained by net profit growing (or shrinking).+87ProfitP/E change: +27 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+27P/EShare count change: −10 pts. Points of the price return explained by the share count changing. More shares count against the price.−10SharesShare price: +104%+104%Share price
Net profit growth+87 ptsNet profit rose about 81%, which lifts the price.
P/E change+27 ptsThe P/E rose from 74.5x to 89.7x, which lifts the price.
Share count change-10 ptsShare count rose 7%, which lowers the price.
What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Not shown for 5 years: earnings were negative at one end, or there is not enough history.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with AARTI INDUSTRIES

How rough has the ride been?

Maximum drawdown-37.3%recovered 2026-03
1-year volatility42.4%annualised
Beta vs sector index0.703-year daily, correlation 0.34
Volume spikes5last 90 sessions, 5x the 50-day median

Drawdown from peak

0%−20%−40%2023202420252026−37.1% 0%−20%−40%2023202420252026−37.1%
Largest drawdowns

-37.3% (2023-06 peak to 2025-09 low, recovered 2026-03)

-21.5% (2026-10 peak to 2026-10 low, not yet recovered)

-19.9% (2022-09 peak to 2022-12 low, recovered 2023-06)

Most recent volume spikes

2026-10-30: 9x the 50-day median, price +2.2% that day

2026-10-06: 6.7x the 50-day median, price +8.4% that day

2026-09-25: 8.3x the 50-day median, price +7.3% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Is it expensive against its own past and its peers?

89.7xP/E todayWithin its usual range
Against its own history48th percentile
CheapestMedian 90.8xDearest

Usual range 64.5x to 139.4x since 2022-06.

Against Process Industries89.7x vs 18.1x
This company
89.7x
Sector median
18.1x

396% above the Process Industries median.

13.7x58.9x104.2x149.4xJun '22May '23Apr '24Mar '25Feb '26Nov '2613.7x58.9x104.2x149.4xJun '22Dec '23Jun '25Nov '26
P/E (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

The chart loads when you open this tab.

P/B (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

The chart loads when you open this tab.

P/S (this company)10th to 90th percentile of its own historyIts medianProcess Industries median
How to read this

Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).

Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.

All terms explained in the glossary →

How Process Industries is valued

Where does it rank among Process Industries peers?

Each cell is the company's percentile rank among its Process Industries peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

  • ROCE54th▲ 9 pts vs a year ago
  • Op. margin97thflat vs a year ago
  • Revenue growth90th▼ 4 pts vs a year ago
  • EPS growth69th▼ 22 pts vs a year ago
  • Debt/equity ↓68th▼ 9 pts vs a year ago
  • Cash cycle ↓7th▲ 4 pts vs a year ago
  • P/E ↓6th▼ 6 pts vs a year ago
  • 12M momentum94th▲ 14 pts vs a year ago

Rank history

ROCE
Op. margin
Revenue growth
EPS growth
Debt/equity ↓
Cash cycle ↓
P/E ↓
12M momentum
Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26
Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Process Industries sector page Watch it move against Process Industries in the Observatory

What is the price implying?

~41%annual earnings growth implied by the price

At a P/E of 151.0x, the price would imply about 41.1%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.

Fewer than six years of annual earnings are available, which is too little to measure delivered growth.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect.

What prices imply across Process Industries The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov
₹1590.10
P/E
89.7x
ROCE
12.0%
Market Cap
₹21108 cr
Revenue (TTM)
₹1231 cr
P/S
17.1x
P/B
8.6x
ROE
9.6%
Operating Margin
31.0%
Debt / Equity
0.2x
Promoter Holding
74.9%
12M Momentum
81.3%

52-week range

₹728.00₹1814.10
79% of the way from its 52-week low to its high

Price risk

1Y volatility
42.4%
Beta vs sector
1-year daily
0.86

Balance sheet & cash

Interest cover
operating profit ÷ interest
17.5x
Cash from profit, 3Y
operating cash flow ÷ net profit
0.49x
low
Share count, 1Y
unchanged

Are profits backed by cash?

4 of 7checks within range2 beyond a threshold
Other income reliance6%Within range

Other income as a share of pre-tax profit (trailing twelve months): 6.4%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate25%Within range

Median quarterly effective tax rate over about 2.5 years: 25.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion0.49xBeyond threshold

Operating cash flow divided by net profit over the last three fiscal years: 0.49x (cash from operations ₹226 cr, net profit ₹459 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow0 of 5 yrsBeyond threshold

Fiscal years with positive free cash flow in the last 5: 0. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history-19 daysWithin range

Debtor days are below the median of the previous three fiscal years by 19 days (123 vs 142). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress34% of fixed assetsNear threshold

Capital work-in-progress is 34% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days+2 days / 2 yrsWithin range

Days payable changed by +2 over two years. Bands: rise of up to 30 days; more than 30 days.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

  • Over 2 years, promoters trimmed 6.9 pts; FIIs added 5.5 pts; DIIs trimmed 1.3 pts.
  • The number of shareholders fell from 84,000 to 65,336 (-22%) between Dec 2023 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupDec '23Jun '26Change
Promoters81.8%74.9%-6.9 pts
FIIs2.0%7.4%+5.5 pts
DIIs11.8%10.5%-1.3 pts
Public and others4.4%7.2%+2.7 pts

Number of shareholders

65,336shareholders-22% since Dec '23
64k71k77k84k Dec '23Jun '24Dec '24Jun '25Dec '25Jun '26
Dec '23: 84,000
Mar '24: 78,655
Jun '24: 71,683
Sep '24: 67,251
Dec '24: 66,677
Mar '25: 64,034
Jun '25: 72,628
Sep '25: 73,806
Dec '25: 67,806
Mar '26: 65,562
Jun '26: 65,336
64k71k77k84k Dec '23Dec '24Dec '25Jun '26
Dec '23: 84,000
Mar '24: 78,655
Jun '24: 71,683
Sep '24: 67,251
Dec '24: 66,677
Mar '25: 64,034
Jun '25: 72,628
Sep '25: 73,806
Dec '25: 67,806
Mar '26: 65,562
Jun '26: 65,336

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

What happened next to similar setups

−15.2%typical 12-month return vs the marketBelow the base rate
  • We found 50 past situations where a non-financial company looked like AETHER INDUSTRIES LIMITED today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
  • Over the following 12 months the middle half of them returned −34% to +13% vs the market, against −6% for all non-financial companies in the same months.
  • The analogs' median sat below that base rate (gap −9.4%, 80% range −15.0% to 0%), but the matches cluster in only 6 distinct 12-month windows.

Where the 50 outcomes landed

−100%−50%0%+50%+100%
COHANCE · Apr 2025: −60.2% vs market
GENESYS · Dec 2024: −54.9% vs market
ANURAS · May 2023: −54.4% vs market
GRANULES · Nov 2020: −48.4% vs market
EPL · Aug 2020: −46.0% vs market
POLYMED · Apr 2025: −44.9% vs market
EMUDHRA · Dec 2024: −42.6% vs market
ANUP · Nov 2024: −40.5% vs market
OLECTRA · Mar 2024: −40.3% vs market
SYRMA · Oct 2023: −39.9% vs market
BIOCON · Jul 2020: −39.8% vs market
SHILPAMED · Sep 2020: −39.2% vs market
JYOTICNC · Apr 2025: −34.7% vs market
FLUOROCHEM · Oct 2022: −33.4% vs market
AURIONPRO · Aug 2024: −25.6% vs market
MATRIMONY · Dec 2020: −24.6% vs market
INDHOTEL · Apr 2025: −24.3% vs market
BORORENEW · May 2022: −23.9% vs market
EIHOTEL · Apr 2024: −23.8% vs market
FORTIS · Oct 2025: −20.6% vs market
MEDANTA · Apr 2024: −18.5% vs market
SHREECEM · Jan 2020: −16.9% vs market
MAXHEALTH · Aug 2025: −16.2% vs market
AFFLE · Apr 2025: −15.9% vs market
ANANTRAJ · Oct 2024: −15.2% vs market
RATEGAIN · Dec 2023: −15.2% vs market
TRENT · Mar 2020: −13.7% vs market
ETHOSLTD · Mar 2024: −7.3% vs market
VIJAYA · Feb 2025: −7.1% vs market
TATACONSUM · Sep 2020: −0.5% vs market
IPCALAB · Feb 2020: −0.2% vs market
LAURUSLABS · Apr 2021: +4.2% vs market
ASTRAMICRO · Jun 2024: +7.1% vs market
SRF · May 2020: +7.3% vs market
PARAS · Apr 2025: +9.5% vs market
DATAPATTNS · Jun 2023: +9.7% vs market
PTCIL · Jul 2025: +12.8% vs market
METROBRAND · Dec 2022: +13.4% vs market
SOLARINDS · Feb 2023: +15.0% vs market
KPITTECH · Jan 2022: +18.8% vs market
LINDEINDIA · Jul 2022: +19.5% vs market
ASTRAL · Mar 2020: +27.7% vs market
SHAILY · Sep 2025: +39.9% vs market
MCX · Apr 2024: +46.8% vs market
AZAD · Oct 2025: +52.3% vs market
KAYNES · Jan 2024: +56.6% vs market
CARTRADE · Jun 2025: +58.0% vs market
NAVINFLUOR · Sep 2025: +77.4% vs market
ATGL · Jan 2020: +92.3% vs market
ACUTAAS · Apr 2025: +115.1% vs market
Similar setups −15.2%All companies −5.8%← worse than the marketbetter than the market →

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 1 beyond the range shown, drawn at the edge

Similar setups' median
−15.2%
All companies' median
−5.8%
Beat the market
38% vs 44%

50 past situations · 50 companies · 35 months · 2020–2025

The closest matches

CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
ACUTAAS
Process Industries
Apr 2025 75x16% +84%−14% +115%
ANANTRAJ
Consumer Durables
Oct 2024 82x9% +205%−5% −15%
RATEGAIN
Technology Services
Dec 2023 115x10% +155%−2% −15%
AZAD
Producer Manufacturing
Oct 2025 105x12% +17%−10% +52%
LAURUSLABS
Health Technology
Apr 2021 95x14% +342%−5% +4%
Show the other 3 matches
CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
MAXHEALTH
Health Services
Aug 2025 104x15% +34%−11% −16%
POLYMED
Health Technology
Apr 2025 81x24% +57%−18% −45%
COHANCE
Health Technology
Apr 2025 69x19% +72%−15% −60%
How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: drawdown from 12-month high, P/E and 12-month momentum. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to AETHER INDUSTRIES LIMITED. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

FeatureWeightNon-financialFinancial
P/E1yesyes
P/S1yes—
P/B1—yes
ROCE1yes—
operating margin1yes—
ROE1—yes
debt/equity0.75yes—
interest cover0.5yes—
revenue growth0.75yesyes
12-month momentum1yesyes
drawdown from 12-month high0.75yesyes
size0.75yesyes
volatility0.5yesyes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

  • One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
  • Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
  • Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
  • Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
  • Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

Health Technology
67%similar
ROCEvolatility
HAPPY FORGINGSHAPPYFORGE
Producer Manufacturing
65%similar
operating marginmarket cap
Consumer Services
57%similar
market capoperating margin
Electronic Technology
57%similar
debt/equityP/E
Health Services
55%similar
volatilitydebt/equity
SUDEEP PHARMASUDEEPPHRM
Process Industries
43%similar
debt/equityoperating margin
Process Industries
43%similar
debt/equityP/E
Process Industries
42%similar
revenue growthpromoter holding

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

30 events since Jun '23

  1. OctPriceVolume reached 9.0x its 50-day median on 2026-10-30; price +2.2% that day.
  2. JulPriceVolume reached 9.4x its 50-day median on 2026-07-31; price +3.3% that day.
  3. JunPeer rankMoved into the 2nd quartile of Process Industries on ROCE (from the 3rd quartile).
  4. JunPriceVolume reached 10.6x its 50-day median on 2026-06-24; price +9.1% that day.
  5. MarPriceRegained the 2023-06 peak, 6 months after the low.
  6. JanPriceVolume reached 16.1x its 50-day median on 2026-01-06; price +5.4% that day.
  7. DecValuationP/E fell below the 10th percentile of its own history to date (58.6x).
  8. NovPriceVolume reached 58.7x its 50-day median on 2025-11-14; price +8.5% that day.
Show 22 earlier events
  1. SepPromoterPromoter holding fell 6.8 pts to 75.0%.
  2. SepInstitutionsFII + DII holding rose 3.7 pts over 1 quarter to 18.4%.
  3. SepPriceFell 37% from the Jun 2023 peak to the Sep 2025 low.
  4. SepPriceVolume reached 20.3x its 50-day median on 2025-09-29; price +2.2% that day.
  5. JunResultsYear-on-year EPS growth turned positive.
  6. JunValuationP/E fell below the 10th percentile of its own history to date (63.7x).
  7. JunPeer rankMoved into the top quartile of Process Industries on EPS growth (from the 3rd quartile).
  8. MayPriceVolume reached 42.9x its 50-day median on 2025-05-14; price -2.2% that day.
  9. JanPriceVolume reached 20.3x its 50-day median on 2025-01-17; price -3.8% that day.
  10. DecResultsRevenue (TTM) reached a new high of ₹652 cr.
  11. DecValuationP/E crossed above the 90th percentile of its own history to date (145.6x).
  12. OctPriceVolume reached 51.4x its 50-day median on 2024-10-15; price -0.8% that day.
  13. SepPriceVolume reached 28.9x its 50-day median on 2024-09-10; price +8.7% that day.
  14. JulSharesShare count is up 6.4% over 12 months.
  15. JunResultsYear-on-year EPS growth turned negative.
  16. JunValuationP/E crossed above the 90th percentile of its own history to date (148.3x).
  17. JunPeer rankSlipped to the 3rd quartile of Process Industries on ROCE (from the 2nd quartile).
  18. JunPriceVolume reached 20.5x its 50-day median on 2024-06-28; price +3.1% that day.
  19. JanDebtDebt / equity halved over 12 months to 0.01x.
  20. NovPriceVolume reached 25.5x its 50-day median on 2023-11-29; price -8.4% that day.
  21. AugPriceVolume reached 5.5x its 50-day median on 2023-08-31; price -1.1% that day.
  22. JunResultsRevenue (TTM) reached a new high of ₹651 cr.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history54 months · 2022-06 to 2026-11
MonthP/ERevenue (TTM)ROEROCEDebt / Equity
2026-1189.7x₹1231 cr9.6%12.0%0.2x
2026-1091.2x₹1231 cr9.6%12.0%0.2x
2026-0995.8x₹1231 cr9.6%12.0%0.2x
2026-08102.2x₹1161 cr8.9%12.0%0.2x
2026-0793.0x₹1161 cr8.9%12.0%0.2x
2026-0682.1x₹1161 cr8.9%12.0%0.2x
2026-0567.5x₹1096 cr9.7%10.0%0.1x
2026-0472.0x₹1096 cr9.7%10.0%0.1x
2026-0367.3x₹1096 cr9.7%10.0%0.1x
2026-0265.3x₹997 cr8.7%10.0%0.1x
2026-0168.3x₹997 cr8.7%10.0%0.1x
2025-1258.6x₹997 cr8.7%10.0%0.1x
2025-1166.3x₹916 cr7.9%10.0%0.1x
2025-1056.9x₹916 cr7.9%10.0%0.1x
2025-0956.8x₹916 cr7.9%10.0%0.1x
2025-0861.6x₹839 cr7.1%10.0%0.1x
2025-0764.2x₹839 cr7.1%10.0%0.1x
2025-0663.7x₹839 cr7.1%10.0%0.1x
2025-0592.6x₹717 cr5.2%7.0%0.1x
2025-04100.0x₹717 cr5.2%7.0%0.1x
2025-03103.2x₹717 cr5.2%7.0%0.1x
2025-02140.5x₹652 cr3.9%7.0%0.1x
2025-01136.1x₹652 cr3.9%7.0%0.1x
2024-12145.6x₹652 cr3.9%7.0%0.1x
2024-11132.0x₹617 cr4.0%7.0%0.1x
2024-10136.9x₹617 cr4.0%7.0%0.1x
2024-09149.5x₹617 cr4.0%7.0%0.1x
2024-08143.1x₹598 cr4.0%7.0%0.1x
2024-07143.8x₹598 cr4.0%7.0%0.1x
2024-06148.3x₹598 cr4.0%7.0%0.1x
2024-0576.8x₹651 cr10.4%18.0%0.0x
2024-0479.6x₹651 cr10.4%18.0%0.0x
2024-0374.6x₹651 cr10.4%18.0%0.0x
2024-0283.9x₹651 cr10.4%18.0%0.0x
2024-0184.4x₹651 cr10.4%18.0%0.0x
2023-1284.7x₹651 cr10.4%18.0%0.0x
2023-1174.5x₹651 cr10.4%18.0%0.0x
2023-1084.1x₹651 cr10.4%18.0%0.0x
2023-0992.5x₹651 cr10.4%18.0%0.0x
2023-0898.0x₹651 cr10.4%18.0%0.0x
2023-0799.1x₹651 cr10.4%18.0%0.0x
2023-06102.0x₹651 cr10.4%18.0%0.0x
2023-0593.2x₹590 cr28.2%—0.8x
2023-0498.0x₹590 cr28.2%—0.8x
2023-0396.9x₹590 cr28.2%—0.8x
2023-0290.5x₹590 cr28.2%—0.8x
2023-0192.1x₹590 cr28.2%—0.8x
2022-1286.8x₹590 cr28.2%—0.8x
2022-1193.3x₹590 cr28.2%—0.8x
2022-1099.9x₹590 cr28.2%—0.8x
2022-0994.4x₹590 cr28.2%—0.8x
2022-0889.3x₹590 cr28.2%—0.8x
2022-0787.6x₹590 cr28.2%—0.8x
2022-0680.7x₹590 cr28.2%—0.8x

Methodology and data notes

Methodology

Methodology and data notes

All figures come from public exchange prices and screener.in financial statements. Quarterly and annual results are shown from 60 days after the period end, so a month never uses a result before it would plausibly have been published. Statements are the latest versions, which may include later restatements.

Sector medians, percentiles and indices use today's listed companies in the sector (survivorship bias). Prices are adjusted for splits and bonus issues; around a corporate action the fundamentals may lag the price by up to a month, and affected sections are hidden.

The return decomposition uses price = P/E × net profit ÷ share count. The reverse DCF uses a fixed 12% cost of equity, a 10-year horizon and a 15x terminal P/E, and is an illustration only. Events, flags and twins follow fixed rules and thresholds described next to each section.

Feedback